LOGO: Truthdig: Drilling Beneath the Headlines. A Progressive Journal of News and Opinion. Editor, Robert Scheer. Publisher, Zuade Kaufman.
2010 Webby Award Winner for Best Political Blog
 
February 20, 2012
Log in / Register

 Choose a size
Text Size

Most Read

Acts of Love

Santorum Staffer Links Obama, Islam Via 'Slip'

OWS Calls for May Day Strike

Ideological Hypocrites

The .0000063% Election

Most Comments
Most Emailed

Reports
Acts of Love
Ideological Hypocrites
The Lowdown on Fracking

Ear to the Ground

A/V Booth

Arts & Culture
Déjà Pooh

Digs
Financial Meltdown 101

Truthdig Bazaar more items

 
Ear to the Ground

Study: Herpes Drug Can Slow HIV Progression

Email this item Email    Print this item Print   

Posted on Feb 15, 2010
aciclovir
Wikimedia Commons / Ragesoss

Tablets of the antiviral drug aciclovir.

A study published in The Lancet has found that aciclovir, a drug frequently used to treat genital herpes, could “help people with HIV infection stay healthy for longer,” according to Dr. Jairam Lingappa, leader of the research team out of the University of Washington in Seattle.  —KA

BBC:

Gus Cairns, editor of HIV Treatment Update, said: “It’s nice to see a positive result in this field.

“There are biological reasons to believe that treating people’s herpes could make them less likely to acquire HIV, or less likely to transmit it if they already have it, but results of trials testing the idea have been disappointing.

“Now at least we find that aciclovir, a very cheap, non-toxic and widely-available drug, can prolong the time some patients may be able to stay off the more expensive, and sometimes toxic, HIV drugs.”

He added that the delay in HIV progression seen in the study may translate into a year or two off HIV medications.

Read more

More Below the Ad

Advertisement


Are you a Truthdig member yet? Login now, or register with Truthdig.

Add Your Comment

Posts by unregistered readers are moderated. Posts by members
are published immediately. Why wait? Register today!






                        Number of characters remaining: 4000

Are you a human? Retype the word you see here.

     

Please read and abide by our comment policy.
By submitting this comment, you agree to this site's terms and conditions.

Newsletter

Get Truthdig in your inbox


 
 
 
Join the Liberal Blog Advertising Network
 
 
 
 
 
 
 

A Progressive Journal of News and Opinion. Editor, Robert Scheer. Publisher, Zuade Kaufman.
Copyright © 2012 Truthdig, L.L.C. All rights reserved.